These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 21333186)
1. Prophylactic laparoscopic gastrectomy for hereditary diffuse gastric cancer: a case series in a single family. Hackenson D; Edelman DA; McGuire T; Weaver DW; Webber JD JSLS; 2010; 14(3):348-52. PubMed ID: 21333186 [TBL] [Abstract][Full Text] [Related]
2. Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in Ithurralde-Argerich J; Rosner L; Rizzolo M; Faerberg A; Puma R; Ferro D; Duque C; Kujaruk M; Cuenca-Abente F J Laparoendosc Adv Surg Tech A; 2021 Jul; 31(7):729-737. PubMed ID: 34097461 [No Abstract] [Full Text] [Related]
4. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512 [TBL] [Abstract][Full Text] [Related]
5. Laparoscopic prophylactic total gastrectomy with limited lymphadenectomy for CDH1 gene carriers. Bryant MK; Sillcox R; Grady WM; Oelschlager BK Surg Endosc; 2023 Dec; 37(12):9373-9380. PubMed ID: 37644154 [TBL] [Abstract][Full Text] [Related]
6. Identification of c.1531C>T Pathogenic Variant in the Norero E; Alarcon MA; Hakkaart C; de Mayo T; Mellado C; Garrido M; Aguayo G; Lagos M; Torres J; Calvo A; Guilford P; Corvalan AH Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600923 [TBL] [Abstract][Full Text] [Related]
7. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer. Chen Y; Kingham K; Ford JM; Rosing J; Van Dam J; Jeffrey RB; Longacre TA; Chun N; Kurian A; Norton JA Ann Surg Oncol; 2011 Sep; 18(9):2594-8. PubMed ID: 21424370 [TBL] [Abstract][Full Text] [Related]
8. Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study. Asif B; Sarvestani AL; Gamble LA; Samaranayake SG; Famiglietti AL; Fasaye GA; Quezado M; Miettinen M; Korman L; Koh C; Heller T; Davis JL Lancet Oncol; 2023 Apr; 24(4):383-391. PubMed ID: 36990610 [TBL] [Abstract][Full Text] [Related]
9. A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer. Seevaratnam R; Coburn N; Cardoso R; Dixon M; Bocicariu A; Helyer L Gastric Cancer; 2012 Sep; 15 Suppl 1():S153-63. PubMed ID: 22160243 [TBL] [Abstract][Full Text] [Related]
10. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications. Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748 [TBL] [Abstract][Full Text] [Related]
11. Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members. Mayrbaeurl B; Keller G; Schauer W; Burgstaller S; Czompo M; Hoebling W; Knoflach P; Duba HC; Hoefler H; Thaler J Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):306-10. PubMed ID: 19474748 [TBL] [Abstract][Full Text] [Related]
12. Total Gastrectomy for CDH-1 Mutation Carriers: An Institutional Experience. DiBrito SR; Blair AB; Prasath V; Habibi M; Harmon JW; Duncan MD J Surg Res; 2020 Mar; 247():438-444. PubMed ID: 31685251 [TBL] [Abstract][Full Text] [Related]